Loss and gain of ceftazidime-avibactam susceptibility in a non-carbapenemase-producing K1-ST23 hypervirulent Klebsiella pneumoniae

被引:0
|
作者
Zhao, Jiankang [1 ,2 ,3 ,4 ,5 ]
Pu, Danni [1 ,2 ,3 ,4 ,5 ,6 ]
Li, Ziyao [1 ,2 ,3 ,4 ,5 ]
Zhang, Yulin [1 ,2 ,3 ,4 ,5 ]
Liu, Xinmeng [1 ,2 ,3 ,4 ,5 ]
Zhuo, Xianxia [1 ,2 ,3 ,4 ,5 ,7 ]
Lu, Binghuai [1 ,2 ,3 ,4 ,5 ,6 ]
Cao, Bin [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
机构
[1] Natl Ctr Resp Med, Beijing, Peoples R China
[2] State Key Lab Resp Hlth & Multimorbid, Beijing, Peoples R China
[3] Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Inst Resp Med, Beijing, Peoples R China
[5] China Japan Friendship Hosp, Ctr Resp Med, Beijing, Peoples R China
[6] Chinese Acad Med Sci, Beijing, Peoples R China
[7] Capital Med Univ, Beijing, Peoples R China
[8] Tsinghua Univ Peaking Univ Joint Ctr Life Sci, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Hypervirulent Klebsiella pneumoniae; ceftazidime-avibactam resistance; CTX-M-71; OmpK36; non-carbapenemase-producing strain; BETA-LACTAMASE; OUTER-MEMBRANE; CLINICAL ISOLATE; ENTEROBACTERIACEAE; RESISTANCE; EMERGENCE; SEQUENCE;
D O I
10.1080/21505594.2024.2348251
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives This study aimed at revealing the underlying mechanisms of the loss and gain of ceftazidime-avibactam susceptibility in a non-carbapenemase-producing hypervirulent Klebsiella pneumoniae (hvKp). Methods Here we longitudinally recovered 3 non-carbapenemase-producing K1-ST23 hvKp strains at a one-month interval (KP29105, KP29499 and KP30086) from an elderly male. Antimicrobial susceptibility testing, whole genome sequencing, transcriptomic sequencing, gene cloning, plasmid conjugation, quantitative real-time PCR (qRT-PCR), and SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) were conducted. Results Among the 3 hvKp strains, KP29105 was resistant to the third- and fourth-generation cephalosporins, KP29499 acquired resistance to both ceftazidime-avibactam and carbapenems, while KP30086 restored its susceptibility to ceftazidime-avibactam, imipenem and meropenem but retained low-level resistance to ertapenem. KP29105 and KP29499 carried plasmid-encoded genes bla(CTX-M-15) and bla(CTX-M-71), respectively, but KP30086 lost both. Cloning of gene bla(CTX-M-71) and conjugation experiment of bla(CTX-M-71)-carrying plasmid showed that the transformant and transconjugant were susceptible to ceftazidime-avibactam but had a more than 8-fold increase in MICs. Supplementation with an outer membrane permeabilizer could reduce the MIC of ceftazidime-avibactam by 32 folds, indicating that porins play a key role in ceftazidime-avibactam resistance. The OmpK35 of the 3 isolates was not expressed, and the OmpK36 of KP29499 and KP30086 had a novel amino acid substitution (L359R). SDS-PAGE and qRT-PCR showed that the expression of porin OmpK36 of KP29499 and KP30086 was significantly down-regulated compared with KP29105. Conclusions In summary, we reported the rare ceftazidime-avibactam resistance in a non-carbapenemase-producing hvKp strain. Resistance plasmid carrying blaCTX-M-71 and mutated OmpK36 had a synergetic effect on the resistance.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Klebsiella pneumoniae from K1 and Hypervirulent Clone ST23: First Documented Case in Portugal
    Pereira, Aida
    Petrucci, Tiago
    Simoes, Maria Joao
    [J]. ACTA MEDICA PORTUGUESA, 2017, 30 (06): : 496 - 499
  • [42] Pharmacokinetic/pharmacodynamic modelling to evaluate the efficacy of various dosing regimens of ceftazidime/avibactam in patients with pneumonia caused by Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae: a multicentre study in northern China
    Kang, Yixin
    Zhou, Qian
    Cui, Junchang
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 27 : 67 - 71
  • [43] Outbreak of Klebsiella pneumoniae ST11 Resistant To Ceftazidime-Avibactam Producing KPC-31 and the Novel Variant KPC-115 during COVID-19 Pandemic in Argentina
    Nicola, Federico
    Cejas, Daniela
    Gonzalez-Espinosa, Francisco
    Relloso, Silvia
    Herrera, Fabian
    Bonvehi, Pablo
    Smayevsky, Jorgelina
    Figueroa-Espinosa, Roque
    Gutkind, Gabriel
    Radice, Marcela
    [J]. MICROBIOLOGY SPECTRUM, 2022, 10 (06):
  • [44] Genomic characterization of an extensively drug-resistant KPC-2-producing Klebsiella pneumoniae ST855 (CC258) only susceptible to ceftazidime-avibactam isolated in Brazil
    Martins Aires, Caio Augusto
    Rybak, Michael J.
    Yim, Juwon
    Pereira, Polyana Silva
    Rocha-de-Souza, Claudio M.
    Albano, Rodolpho Mattos
    Cavalcanti, Valdelucia Oliveira
    D'Alincourt Carvalho-Assef, Ana Paula
    Ribeiro Gomes, Marisa Zenaide
    Asensi, Marise Dutra
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 89 (04) : 324 - 327
  • [45] Epidemiology and in vitro activity of ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates (vol 50, pg 467, 2022)
    Maraki, Sofia
    Mavromanolaki, Viktoria Eirini
    Magkafouraki, Eleni
    Moraitis, Panagiotis
    Stafylaki, Dimitra
    Kasimati, Anna
    Scoulica, Effie
    [J]. INFECTION, 2022, 50 (06) : 1639 - 1639
  • [46] Outbreak of KPC-2-producing Klebsiella pneumoniae endowed with ceftazidime-avibactam resistance mediated through a VEB-1-mutant (VEB-25), Greece, September to October 2019
    Galani, Irene
    Karaiskos, Ilias
    Souli, Maria
    Papoutsaki, Vassiliki
    Galani, Lamprini
    Gkoufa, Aikaterini
    Antoniadou, Anastasia
    Giamarellou, Helen
    [J]. EUROSURVEILLANCE, 2020, 25 (03): : 10 - 16
  • [47] Co-occurrence of Rapid Gene Gain and Loss in an Interhospital Outbreak of Carbapenem-Resistant Hypervirulent ST11-K64 Klebsiella pneumoniae
    Zhang, XiaoTuan
    Ouyang, JingLin
    He, WenWen
    Zeng, Tong
    Liu, Bin
    Jiang, Hongtao
    Zhang, Yunsheng
    Zhou, Linlin
    Zhou, Haijian
    Liu, Zhuoran
    Liu, Logen
    [J]. FRONTIERS IN MICROBIOLOGY, 2020, 11
  • [48] Multicentre investigation of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Bulgarian hospitals - Interregional spread of ST11 NDM-1-producing K. pneumoniae
    Markovska, Rumyana
    Stoeva, Temenuga
    Boyanova, Lyudmila
    Stankova, Petya
    Schneider, Ines
    Keuleyan, Emma
    Mihova, Kalina
    Murdjeva, Marianna
    Sredkova, Mariya
    Lesseva, Magdalena
    Nedelcheva, Gergana
    Petrova, Atanaska
    Ivanova, Dobrinka
    Lazarova, Grozdanka
    Kaneva, Radka
    Mitov, Ivan
    [J]. INFECTION GENETICS AND EVOLUTION, 2019, 69 : 61 - 67
  • [49] Genomic characterization of a new phage BUCT541 against Klebsiella pneumoniae K1-ST23 and efficacy assessment in mouse and Galleria mellonella larvae
    Pu, Mingfang
    Li, Yahao
    Han, Pengjun
    Lin, Wei
    Geng, Ronghua
    Qu, Fen
    An, Xiaoping
    Song, Lihua
    Tong, Yigang
    Zhang, Shuyan
    Cai, Zhen
    Fan, Huahao
    [J]. FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [50] Failure of ceftazidime/avibactam experimental therapy in the treatment of Klebsiella pneumoniae ST11 co-producing NDM-1 and OXA-48 carbapenemases infection
    Nikbin, Vajihe Sadat
    Khiavi, Elham Haj Agha Gholizadeh
    Dehghani-Latani, Mehdi
    Hosseinzadeh, Majid
    Shirzadi, Mohammad
    Pourajam, Samaneh
    Nouri, Samereh
    Solgi, Hamid
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024,